BPC
REGN icon

Banque Pictet & Cie’s Regeneron Pharmaceuticals REGN Stock Holding History

Banque Pictet & Cie’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Sell
3,713
-6,180
-62% -$4.21M 0.01% 187
2026
Q1 		$7.64M Sell
9,893
-1,929
-16% -$1.48M 0.05% 126
2025
Q4 		$9.13M Buy
11,822
+1,234
+12% +$838K 0.05% 120
2025
Q3 		$5.95M Buy
10,588
+5,115
+93% +$2.89M 0.03% 135
2025
Q2 		$2.87M Sell
5,473
-664
-11% -$371K 0.02% 191
2025
Q1 		$3.89M Sell
6,137
-175
-3% -$120K 0.03% 167
2024
Q4 		$4.5M Buy
+6,312
New +$5.3M 0.03% 161
2023
Q4 		– Sell
-617
Closed -$508K – 449
2023
Q3 		$508K Sell
617
-1,772
-74% -$1.39M 0.01% 337
2023
Q2 		$1.72M Sell
2,389
-1,494
-38% -$1.15M 0.02% 265
2023
Q1 		$3.19M Sell
3,883
-6,456
-62% -$4.87M 0.03% 214
2022
Q4 		$7.46M Sell
10,339
-624
-6% -$460K 0.08% 127
2022
Q3 		$7.55M Buy
10,963
+1,185
+12% +$746K 0.08% 121
2022
Q2 		$5.78K Buy
9,778
+8,850
+954% +$5.75M 0.06% 161
2022
Q1 		$648K Hold
928
– – 0.01% 492
2021
Q4 		$586K Hold
928
– – ﹤0.01% 514
2021
Q3 		$562K Hold
928
– – 0.01% 292
2021
Q2 		$518K Hold
928
– – 0.01% 294
2021
Q1 		$439K Hold
928
– – 0.01% 300
2020
Q4 		$448K Hold
928
– – 0.01% 275
2020
Q3 		$519K Hold
928
– – 0.01% 253
2020
Q2 		$579K Hold
928
– – 0.01% 251
2020
Q1 		$453K Hold
928
– – 0.01% 264
2019
Q4 		$348K Buy
+928
New +$312K 0.01% 311
2018
Q4 		– Sell
-780
Closed -$315K – 344
2018
Q3 		$315K Sell
780
-583
-43% -$222K 0.01% 320
2018
Q2 		$470K Sell
1,363
-5,964
-81% -$1.87M 0.01% 275
2018
Q1 		$2.52M Sell
7,327
-400
-5% -$139K 0.05% 193
2017
Q4 		$2.9M Sell
7,727
-1,318
-15% -$534K 0.06% 180
2017
Q3 		$4.04M Buy
9,045
+1,455
+19% +$692K 0.09% 153
2017
Q2 		$3.73M Buy
+7,590
New +$3.32M 0.09% 156

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Banque Pictet & Cie's REGN Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Regeneron Pharmaceuticals (REGN) stake by 62% in Q2 2026, selling an estimated $4.21M and leaving 3,713 shares worth $2.32M. The position accounts for 0.01% of the portfolio, ranked #187.

Banque Pictet & Cie first reported a position in REGN in Q2 2017 and has held it in 29 quarters since. The position peaked at $9.13M in Q4 2025. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Banque Pictet & Cie held 3,713 shares of Regeneron Pharmaceuticals worth $2.32M as of Q2 2026.
  • Banque Pictet & Cie sold 6,180 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.21M.
  • Regeneron Pharmaceuticals made up 0.01% of Banque Pictet & Cie's portfolio in Q2 2026, its #187 holding.
  • Banque Pictet & Cie first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 29 quarters since.
  • Banque Pictet & Cie's Regeneron Pharmaceuticals position peaked at $9.13M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.